- 全部删除
您的购物车当前为空
Pyrazinamide (Pyrazinecarboxamide) 是一种口服抗结核类抗生素。它是一种前药,通过结核分枝杆菌pncA 基因编码的 PZase/烟酰胺酶转化为活性吡嗪酸形式。

Pyrazinamide (Pyrazinecarboxamide) 是一种口服抗结核类抗生素。它是一种前药,通过结核分枝杆菌pncA 基因编码的 PZase/烟酰胺酶转化为活性吡嗪酸形式。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 500 mg | ¥ 326 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 395 | In stock |
Pyrazinamide 相关产品
| 产品描述 | Pyrazinamide (Pyrazinecarboxamide), an antimycobacterial, is utilized therapeutically as an antitubercular agent, which is a synthetic pyrazinoic acid amide derivative. |
| 别名 | 吡嗪酰胺, Pyrazinoic acid amide, Pyrazinecarboxamide |
| 分子量 | 123.11 |
| 分子式 | C5H5N3O |
| CAS No. | 98-96-4 |
| Smiles | NC(=O)C1=NC=CN=C1 |
| 密度 | 1.3260 g/cm3 (Estimated) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: 2 mg/mL (16.25 mM), Sonication is recommended. DMSO: 20 mg/mL (162.46 mM), Sonication is recommended. H2O: 10 mg/mL (81.23 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (16.25 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||||||||||||
Ethanol/H2O/DMSO
H2O/DMSO
DMSO
| ||||||||||||||||||||||||||||||||||||||||||||||
评论内容